Przedsi#biorstwo Farmaceutyczne Lek Salmeterol Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Salmeterol from India and how much does Przedsi#biorstwo Farmaceutyczne Lek import?

India exports Salmeterol to 370 buyers globally worth $22.8M. Przedsi#biorstwo Farmaceutyczne Lek imports $400.0K (0.5% market share) with 8 shipments from POLAND.

Q: What is the average order value for Przedsi#biorstwo Farmaceutyczne Lek's Salmeterol imports?

Przedsi#biorstwo Farmaceutyczne Lek's average Salmeterol order value is $50.0K per consignment, based on 8 shipments totaling $400.0K.

Q: Who supplies Salmeterol to Przedsi#biorstwo Farmaceutyczne Lek?

Top Indian Salmeterol suppliers: CIPLA LIMITED ($55.7M), HETERO LABS LIMITED ($6.4M), MEDISPRAY LABORATORIES PRIVATE LIMITED ($1.1M), ZYDUS LIFESCIENCES LIMITED ($1.1M), VAMSI PHARMA PRIVATE LIMITED ($900.0K).

Q: How does Przedsi#biorstwo Farmaceutyczne Lek compare to other Salmeterol importers?

Przedsi#biorstwo Farmaceutyczne Lek ranks #15 among 370 Salmeterol importers from India with 0.5% market share and 8 shipments.

Q: Who are the top Salmeterol importers from India?

Top Salmeterol importers: CIPLA MAROC ($4.4M), PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR ($3.3M), BREATHEFREE LANKA PVT LTD ($2.1M), LABORATORIOS RECALCINE SA.. ($2.0M), H.ESSERS & ZONEN INTERNATIONAL TRAN ($1.8M).

Suresh Sormare

Salmeterol

India Pharmaceutical Trade Intelligence

$72.8M148 Suppliers90 CountriesHS 30049099

ExportsIndia → CHILE13.4%India → TURKEY10.8%

#1 Supplier: CIPLA LIMITED #1 Buyer: PAYAZ BIOMEDIKAL

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol Importer #15 | $400.0K Trade Value | TransData Nexus | TransData Nexus

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol Importer Profile

Pharmaceutical Importer · #15 buyer for Salmeterol · $400.0K import value · 8 shipments · POLAND · DGFT Verified

Przedsi#biorstwo Farmaceutyczne Lek is the #15 importer of Salmeterol from India with $400.0K in import value and 8 verified shipments. Przedsi#biorstwo Farmaceutyczne Lek holds a 0.5% market share in Salmeterol imports based in POLAND.

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol Import Profile: Suppliers, Formulations & Sources

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol import analysis from Indian Customs (DGFT) data.

Who Supplies Salmeterol to Przedsi#biorstwo Farmaceutyczne Lek?

Supplier	Value	Shipments	% Share
CIPLA LIMITED	$55.7M	1,265	44
HETERO LABS LIMITED	$6.4M	139	4
MEDISPRAY LABORATORIES PRIVATE LIMITED	$1.1M	22	1
ZYDUS LIFESCIENCES LIMITED	$1.1M	64

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Salmeterol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: Przedsi#biorstwo Farmaceutyczne Lek matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as Przedsi#biorstwo Farmaceutyczne Lek's capped import value divided by total capped export value for Salmeterol across all Indian exporters.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 90+ countries, 370+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Salmeterol

Salmeterol

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol Importer Profile

Przedsi#biorstwo Farmaceutyczne Lek — Salmeterol Import Profile: Suppliers, Formulations & Sources

Who Supplies Salmeterol to Przedsi#biorstwo Farmaceutyczne Lek?

Who Are the Top Buyers of Salmeterol from India and How Much Does Przedsi#biorstwo Farmaceutyczne Lek Import?

What Is the Average Order Value for Przedsi#biorstwo Farmaceutyczne Lek's Salmeterol Imports?

Who Supplies Salmeterol to Przedsi#biorstwo Farmaceutyczne Lek?

How Does Przedsi#biorstwo Farmaceutyczne Lek Compare to Other Salmeterol Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Salmeterol Import Data for Przedsi#biorstwo Farmaceutyczne Lek

Przedsi#biorstwo Farmaceutyczne Lek × Salmeterol

Related Analysis

Need Detailed Import Data?

Data Source